Charles C. Irving
- Molecular Biology top 10%
- Cancer Research top 5%
- Biochemistry top 2%
- Organic Chemistry top 10%
- Pharmacology top 2%
- Co-authors
- Ray CoxCarlton D. JacksonWilliam M. MurphyHeike GutmannRichard C. MoonCarolyn J. DouglasJ. H. WeisburgerLionel A. Poirier
- Topics
- Carcinogens and Genotoxicity Assessment (10 papers)DNA Repair Mechanisms (9 papers)Bladder and Urothelial Cancer Treatments (7 papers)
- Partner nations
- United StatesNetherlands
In The Last Decade
Charles C. Irving
68 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 94
- Molecular Biology 925
- Cancer Research 578
- Biochemistry 235
- Organic Chemistry 233
- Pharmacology 198
Countries citing papers authored by Charles C. Irving
This map shows the geographic impact of Charles C. Irving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles C. Irving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles C. Irving more than expected).
Fields of papers citing papers by Charles C. Irving
This network shows the impact of papers produced by Charles C. Irving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles C. Irving. The network helps show where Charles C. Irving may publish in the future.
Co-authorship network of co-authors of Charles C. Irving
This figure shows the co-authorship network connecting the top 25 collaborators of Charles C. Irving. A scholar is included among the top collaborators of Charles C. Irving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles C. Irving. Charles C. Irving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 6 | |
| 3 | 13 | |
| 4 | 2 | |
| 5 | 14 | |
| 6 | 17 | |
| 7 | 13 | |
| 8 | 18 | |
| 9 | Biochemically detectable tumor markers in urine of bladder cancer patients. | 7 |
| 10 | 28 | |
| 11 | 34 | |
| 12 | Effects of 2-acetylaminofluorene on liver cell proliferation after partial hepatectomy of female rats. | 24 |
| 13 | 3 | |
| 14 | 5 | |
| 15 | Influence of 3-methylcholanthrene and diet on the binding of 2-acetylaminofluroene and its N-hydroxy metabolite to rat liver nucleic acids. | 11 |
| 16 | 2 | |
| 17 | 56 | |
| 18 | N-Hydroxylation of 2-Acetylaminofluorene in the Rabbit | 41 |
| 19 | 4 | |
| 20 | 1 |
About Charles C. Irving
Charles C. Irving is a scholar working on Biochemistry, Cancer Research and Pharmaceutical Science, having authored 68 papers that have together received 1.6k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (10 papers), DNA Repair Mechanisms (9 papers) and Bladder and Urothelial Cancer Treatments (7 papers). The work is most often cited by research in Cancer Research (578 citations), Biochemistry (235 citations) and Pharmacology (198 citations). Charles C. Irving has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Ray Cox, Carlton D. Jackson, William M. Murphy, Heike Gutmann, Richard C. Moon, Carolyn J. Douglas, J. H. Weisburger, Lionel A. Poirier, H. F. Stich and D.R. Stoltz. Their work appears in journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.